title: Molecular topology as a novel approach for drug discovery.
abstract: BACKGROUND
  Molecular topology (MT) has emerged in recent years as a powerful approach for the in silico generation of new drugs. One key part of MT is that, in the process of drug design/discovery, there is no need for an explicit knowledge of a drug's mechanism of action unlike other drug discovery methods.
  
  
  METHODS
  In this review, the authors introduce the topic by explaining briefly the most common methodology used today in drug design/discovery and address the most important concepts of MT and the methodology followed (QSAR equations, LDA, etc.). Furthermore, the significant results achieved, from this approach, are outlined and discussed.
  
  
  CONCLUSIONS
  The results outlined herein can be explained by considering that MT represents a new paradigm in the field of drug design. This means that it is not only an alternative method to the conventional methods, but it is also independent, that is, it represents a pathway to connect directly molecular structure with the experimental properties of the compounds (particularly drugs). Moreover, the process can be realized also in the reverse pathway, that is, designing new molecules from their topological pattern, what opens almost limitless expectations in new drugs development, given that the virtual universe of molecules is much greater than that of the existing ones.
authors.affiliation: University of Valencia Avd, Department of Physical Chemistry, Molecular Connectivity and Drug Design Research Unit, Valencia, Spain. jorge.galvez@uv.es
authors.forename: Jorge
authors.initials: J
authors.lastname: Gálvez
authors.forename: María
authors.initials: M
authors.lastname: Gálvez-Llompart
authors.forename: Ramón
authors.initials: R
authors.lastname: García-Domenech
mesh_terms: D000818:Animals; D017076:Computer-Aided Design; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D004345:Drug Industry / Q000379:methods; D006801:Humans; D008962:Models, Theoretical; D004364:Pharmaceutical Preparations / Q000737:chemistry; D021281:Quantitative Structure-Activity Relationship
chemical_list: D004364:Pharmaceutical Preparations